Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

476.42
-0.01000.00%
Post-market: 476.420.00000.00%19:30 EDT
Volume:4.02M
Turnover:1.91B
Market Cap:23.61B
PE:45.29
High:481.17
Open:477.43
Low:465.02
Close:476.43
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:6.82
T/O Rate:8.35%
Dividend:0.80
Dividend Rate:0.17%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:10.60
PE(LYR):45.29

Loading ...

U.S. RESEARCH ROUNDUP-Asana, PPG Industries, Verisign

Reuters
·
Apr 01

Over 70 Million Taxpayers Apply for Refunds, 5 Million Voluntarily Report Additional Tax Liabilities

Deep News
·
Apr 01

Tax Administration Reports Over 70 Million Taxpayers Applied for Income Tax Refunds

Deep News
·
Apr 01

Carpenter Technology (CRS) Receives a Hold from Wells Fargo

TIPRANKS
·
Apr 01

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

GlobeNewswire
·
Mar 27

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 27

Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 26

Assessing Carpenter Technology (CRS) Valuation After Strong Multi‑Year Shareholder Returns

Simply Wall St.
·
Mar 24

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 23

Nyse Order Imbalance 162570.0 Shares on Sell Side

THOMSON REUTERS
·
Mar 21

Press Release: Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

Dow Jones
·
Mar 20

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

GlobeNewswire
·
Mar 20

Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs

prnewswire
·
Mar 18

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

GlobeNewswire
·
Mar 18

A Look At Carpenter Technology (CRS) Valuation After A Strong Multi Year Share Price Run

Simply Wall St.
·
Mar 16

Press Release: Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 11

Is Strong Q2 Beat And Higher Guidance Altering The Investment Case For Carpenter Technology (CRS)?

Simply Wall St.
·
Mar 04

Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

prnewswire
·
Mar 04

Carpenter Tech Initiated at Positive by Susquehanna

Dow Jones
·
Mar 03

Susquehanna Initiates Carpenter Technology at Positive With $470 Price Target

MT Newswires Live
·
Mar 03